Literature DB >> 9096175

Anaphylaxis in children: a 5-year experience.

S D Dibs1, M D Baker.   

Abstract

OBJECTIVES: To identify the causative agents, presenting signs and symptoms, and course of disease in children diagnosed with anaphylaxis. Design. Five-year retrospective chart review.
SETTING: Urban children's hospital pediatric emergency department, operating suite, and inpatient units. PARTICIPANTS: Fifty-five cases of anaphylaxis in 50 patients 1 to 19 years of age.
INTERVENTIONS: None.
RESULTS: The most common inciting agents in this population were latex (27%), food (25%), drugs (16%), and venoms (15%). Thirty-two cases (58%) occurred outside of the hospital, including 3 of 11 severe cases. Nineteen (35%) had histories of prior allergy to the causative agent. Most agent exposures were intravenous (38%), oral (27%), or dermal (20%). The most common systems involved were respiratory (93%), skin (93%), cardiovascular (26%), and neurologic (26%). Features distinguishing the 11 patients requiring intensive care included latex agents (45%), nonenteral route of exposure (91%), and presence of cardiovascular symptoms (45%). Of the 17 patients with known past anaphylaxis, only 5 had epinephrine self-administration devices available, and 3 had used them.
CONCLUSIONS: (1) Most patients with anaphylaxis present with skin or respiratory symptoms. (2) Severely ill children more commonly have nonenteral and/or latex exposures that occur in the hospital. (3) Most children with anaphylaxis have no stated histories of prior reaction to the causative agent. (4) Those patients who have had past episodes of anaphylaxis infrequently have epinephrine self-administration devices available for use.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9096175     DOI: 10.1542/peds.99.1.e7

Source DB:  PubMed          Journal:  Pediatrics        ISSN: 0031-4005            Impact factor:   7.124


  10 in total

1.  Hospital admissions for acute anaphylaxis: time trend study.

Authors:  A Sheikh; B Alves
Journal:  BMJ       Date:  2000-05-27

Review 2.  The Epidemiology of Anaphylaxis.

Authors:  Joyce E Yu; Robert Y Lin
Journal:  Clin Rev Allergy Immunol       Date:  2018-06       Impact factor: 8.667

3.  Pediatric anaphylaxis management in the prehospital setting.

Authors:  Gunjan Kamdar Tiyyagura; Linda Arnold; David C Cone; Melissa Langhan
Journal:  Prehosp Emerg Care       Date:  2013-09-12       Impact factor: 3.077

4.  Case fatality and population mortality associated with anaphylaxis in the United States.

Authors:  Larry Ma; Theodore M Danoff; Larry Borish
Journal:  J Allergy Clin Immunol       Date:  2013-12-14       Impact factor: 10.793

5.  Acute treatment of anaphylaxis in children.

Authors:  Ran D Goldman
Journal:  Can Fam Physician       Date:  2013-07       Impact factor: 3.275

6.  Anaphylaxis in referred pediatric patients: demographic and clinical features, triggers, and therapeutic approach.

Authors:  Liliane F A De Swert; Dominique Bullens; Marc Raes; Anna-Maria Dermaux
Journal:  Eur J Pediatr       Date:  2008-01-17       Impact factor: 3.183

Review 7.  Epidemiology of anaphylaxis in the United States.

Authors:  Matthew J Matasar; Alfred I Neugut
Journal:  Curr Allergy Asthma Rep       Date:  2003-01       Impact factor: 4.919

8.  Downstream consequences of diagnostic error in pediatric anaphylaxis.

Authors:  H Thomson; R Seith; S Craig
Journal:  BMC Pediatr       Date:  2018-02-07       Impact factor: 2.125

9.  Self-administration of epinephrine in children: a survey of current prescription practice and recommendations for improvement.

Authors:  J L Hughes; M Stewart
Journal:  Ulster Med J       Date:  2003-11

10.  Use of multiple epinephrine doses in anaphylaxis: A systematic review and meta-analysis.

Authors:  Nandinee Patel; Kok Wee Chong; Alexander Y G Yip; Despo Ierodiakonou; Joan Bartra; Robert J Boyle; Paul J Turner
Journal:  J Allergy Clin Immunol       Date:  2021-04-20       Impact factor: 10.793

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.